🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jeremy Chataway

Queen Mary University of London

ORCID: 0000-0001-7286-6901

Also affiliated with National Institute for Health and Care Research, National Hospital for Neurology and Neurosurgery, University College London

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.487Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Enabling new insights from old scans by repurposing clinical MRI archives for multiple sclerosis research

Nature Communications(2025)10.1038/s41467-025-58274-8
Top 39%
0.487DataRank
Top 39%16 citations

Jed Wingrove, Omar Abdelmannan, Barbara Brito Vega, Jonathan Stutters, Silvia Da Graca Ramos +19 more

Papers

Driven by 8 papers — median percentile 61. Top paper: “Enabling new insights from old scans by repurposing clinical MRI archives for multiple sclerosis research”.

Enabling new insights from old scans by repurposing clinical MRI archives for multiple sclerosis research

Nature Communications(2025)10.1038/s41467-025-58274-8
Top 39%
0.487DataRank
Top 39%16 citations

Jed Wingrove, Omar Abdelmannan, Barbara Brito Vega, Jonathan Stutters, Silvia Da Graca Ramos +19 more

The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience

Journal of Neurology(2021)10.1007/s00415-021-10881-3
N/A
0.269DataRank · unranked
5 citations

Maria Pia Amato, Giampaolo Brichetto, Jeremy Chataway, Nancy D. Chiaravalloti, Gary Cutter +13 more

Multiple sclerosis progression: time for a new mechanism-driven framework

The Lancet Neurology(2022)10.1016/s1474-4422(22)00289-7
N/A
0DataRank · unranked
631 citations

Marcello Moccia, Timothy Coetzee, Jeffrey A. Cohen, Jorge Correale, Jennifer Graves +29 more

The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis

Journal of Neurology(2020)10.1007/s00415-020-10160-7
N/A
0DataRank · unranked
71 citations

Maria Pia Amato, Giampaolo Brichetto, Jeremy Chataway, Ulrik Dalgas, John DeLuca +13 more

Longitudinal network-based brain grey matter MRI measures are clinically relevant and sensitive to treatment effects in multiple sclerosis

Brain Communications(2024)10.1093/braincomms/fcae234
N/A
0DataRank · unranked
3 citations

Jonathan Stutters, Sridar Narayanan, Douglas L. Arnold, Jeremy Chataway, Claudia A. M. Gandini Wheeler‐Kingshott +5 more

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria

The Lancet Neurology(2025)10.1016/s1474-4422(25)00270-4
N/A
0DataRank · unranked
327 citations

Christine Lebrun‐Frénay, Jiwon Oh, Georgina Arrambide, Marcello Moccia, Maria Pia Amato +51 more

Improving the efficiency of clinical trials in multiple sclerosis

Multiple Sclerosis Journal(2023)10.1177/13524585231189671
N/A
0DataRank · unranked
19 citations

Maria Pia Sormani, Sean Apap Mangion, Francesca Bovis, Winson Y. Cheung, Gary Cutter +10 more

Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT

Efficacy and Mechanism Evaluation(2020)10.3310/eme07030
N/A
0DataRank · unranked
27 citations

Peter Connick, Richard Parker, Domenico Plantone, Anisha Doshi, Nevin John +23 more